Mucinous adenocarcinoma of the appendix

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:391723C18.1
Who is this for?
Show terms as
1FDA treatments2Active trials35Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mucinous adenocarcinoma of the appendix is a rare type of cancer that starts in the appendix, a small pouch attached to the large intestine. This cancer is called "mucinous" because the tumor cells produce a thick, jelly-like substance called mucin. It is sometimes referred to as appendiceal mucinous adenocarcinoma or mucinous appendiceal cancer. Unlike more common cancers, this type can behave in unusual ways — it may spread mucin-producing cells throughout the abdominal cavity, a condition known as pseudomyxoma peritonei (PMP), where jelly-like material fills the belly. Many people have no symptoms early on. The disease is often discovered unexpectedly during surgery for what appears to be appendicitis or during imaging done for other reasons. When symptoms do occur, they may include abdominal pain (often in the lower right side), bloating, a growing waistline without weight gain elsewhere, changes in bowel habits, or a mass felt in the abdomen. Some patients experience nausea, loss of appetite, or pelvic pressure. Treatment typically involves surgery to remove the appendix and surrounding tissue. In more advanced cases, especially when the cancer has spread within the abdomen, a specialized procedure called cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC) may be recommended. This involves removing all visible tumor from the abdominal cavity and then bathing the area in heated chemotherapy. Systemic chemotherapy may also be used. Because this cancer is rare, treatment is best managed at specialized centers with experience in peritoneal surface cancers.

Also known as:

Key symptoms:

Abdominal pain, often in the lower right sideAbdominal bloating or swellingIncreasing waist size without overall weight gainA lump or mass felt in the abdomenChanges in bowel habits such as constipation or diarrheaNausea or vomitingLoss of appetiteUnexplained weight lossPelvic pressure or discomfortSymptoms mimicking appendicitisFeeling full quickly when eatingFatigueNew onset hernia

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Mar 2026Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Peking University — PHASE1

TrialNOT YET RECRUITING
Oct 2022METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin

University Hospital, Akershus — PHASE2

TrialACTIVE NOT RECRUITING
Jul 2013Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

M.D. Anderson Cancer Center — NA

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

IMFINZI

durvalumab· AstraZeneca Pharmaceuticals LP
in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy as neoadjuvant and adjuvant treatment, followed by single agent IMFINZI, for the treatment of adult patient

in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy as neoadjuvant and adjuvant treatment, followed by single agent IMFINZI, for the treatment of adult patients with resectable gastric or gastroesophageal junction adenocarcinoma (GC/GEJC)

Clinical Trials

2 recruitingView all trials with filters →
Phase 21 trial
METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin
Phase 2
Active
PI: Christian Kersten, MD, PhD (University Hospital, Akershus) · Sites: Lørenskog, Akershus; Oslo, Akershus +1 more · Age: 1899 yrs
N/A1 trial
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
N/A
Active
PI: Keith F. Fournier, MD (M.D. Anderson Cancer Center) · Sites: Houston, Texas · Age: 1899 yrs

Specialists

Showing 25 of 35View all specialists →
MS
Michelle Sittig
Specialist
1 Mucinous adenocarcinoma of the appendix publication
PM
Paul H McClelland
CINCINNATI, OH
Specialist
2 Mucinous adenocarcinoma of the appendix publications
VG
Vadim Gushchin
BUFFALO, NY
Specialist
1 Mucinous adenocarcinoma of the appendix publication
SN
Shirley K Nah
SAN ANTONIO, TX
Specialist
1 Mucinous adenocarcinoma of the appendix publication
JH
Jonathan M Hernandez
Specialist
1 Mucinous adenocarcinoma of the appendix publication
FL
Felipe Lopez-Ramirez
Specialist
1 Mucinous adenocarcinoma of the appendix publication
MK
Mary Caitlin King
Specialist
1 Mucinous adenocarcinoma of the appendix publication
EB
Ekaterina Baron
MARSHFIELD, WI
Specialist
1 Mucinous adenocarcinoma of the appendix publication
AS
Armando Sardi
BALTIMORE, MD
Specialist
1 Mucinous adenocarcinoma of the appendix publication
CN
Carol Nieroda
LAUREL, MD
Specialist
1 Mucinous adenocarcinoma of the appendix publication
AN
Andrei Nikiforchin
Specialist
1 Mucinous adenocarcinoma of the appendix publication
AB
Andrew M Blakely
COLUMBUS, OH
Specialist
2 Mucinous adenocarcinoma of the appendix publications
KT
Kevin M Turner
Specialist
1 Mucinous adenocarcinoma of the appendix publication
SP
Sameer H Patel
Specialist
1 Mucinous adenocarcinoma of the appendix publication
SG
Stephanie N Gregory
Specialist
1 Mucinous adenocarcinoma of the appendix publication
DG
David M Gershenson
HOUSTON, TX
Specialist
PI on 3 active trials4 Mucinous adenocarcinoma of the appendix publications
JC
John K Chan
Specialist
PI on 3 active trials103 Mucinous adenocarcinoma of the appendix publications
FF
Faheez Mohamed, MBChB, MD, FRCS
Specialist
PI on 1 active trial
RB
Robert Burger
Specialist
PI on 1 active trial11 Mucinous adenocarcinoma of the appendix publications
HP
Henry Pitot
ROCHESTER, MN
Specialist
PI on 2 active trials2 Mucinous adenocarcinoma of the appendix publications
MG
Michael Gold
Specialist
PI on 1 active trial28 Mucinous adenocarcinoma of the appendix publications
EM
Evanthia Galanis, MD
ROCHESTER, MN
Specialist
PI on 9 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
IMFINZI(durvalumab)AstraZeneca Pharmaceuticals LP

Travel Grants

No travel grants are currently matched to Mucinous adenocarcinoma of the appendix.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mucinous adenocarcinoma of the appendixForum →

No community posts yet. Be the first to share your experience with Mucinous adenocarcinoma of the appendix.

Start the conversation →

Latest news about Mucinous adenocarcinoma of the appendix

No recent news articles for Mucinous adenocarcinoma of the appendix.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact grade and stage of my appendiceal cancer, and what does that mean for my outlook?,Am I a candidate for cytoreductive surgery with HIPEC, and should I be referred to a specialized center?,What chemotherapy options are available for my specific situation, and what are the expected side effects?,Should molecular or genetic testing be done on my tumor to guide treatment decisions?,How often will I need follow-up imaging and blood tests, and what will you be looking for?,Are there any clinical trials available for appendiceal mucinous adenocarcinoma that I might be eligible for?,What symptoms should prompt me to seek emergency care between appointments?

Common questions about Mucinous adenocarcinoma of the appendix

What is Mucinous adenocarcinoma of the appendix?

Mucinous adenocarcinoma of the appendix is a rare type of cancer that starts in the appendix, a small pouch attached to the large intestine. This cancer is called "mucinous" because the tumor cells produce a thick, jelly-like substance called mucin. It is sometimes referred to as appendiceal mucinous adenocarcinoma or mucinous appendiceal cancer. Unlike more common cancers, this type can behave in unusual ways — it may spread mucin-producing cells throughout the abdominal cavity, a condition known as pseudomyxoma peritonei (PMP), where jelly-like material fills the belly. Many people have no

How is Mucinous adenocarcinoma of the appendix inherited?

Mucinous adenocarcinoma of the appendix follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mucinous adenocarcinoma of the appendix typically begin?

Typical onset of Mucinous adenocarcinoma of the appendix is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Mucinous adenocarcinoma of the appendix?

Yes — 2 recruiting clinical trials are currently listed for Mucinous adenocarcinoma of the appendix on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Mucinous adenocarcinoma of the appendix?

25 specialists and care centers treating Mucinous adenocarcinoma of the appendix are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.